3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
7
Carcinoma, Non-Small-Cell Lung
4
Triple Negative Breast Neoplasms
3
Hodgkin Disease
3
Rhabdomyosarcoma, Embryonal
2
Rhabdomyosarcoma, Alveolar
2
Rhabdomyosarcoma
2
Neoplasm Metastasis
2
Uterine Cervical Neoplasms
1
Sarcoma
1
Recurrence
1
Neoplasms
1
Lung Neoplasms
1
Lung Diseases, Interstitial
1
HR+HER2- Breast Cancer
1
Desmoplastic Small Round Cell Tumor
1
Adenocarcinoma
1
Interventions
Rituximab
13
Cyclophosphamide
9
Magnetic Resonance Spectroscopy
7
Lenalidomide
7
venetoclax
6
obinutuzumab
5
ibrutinib
5
Specimen Handling
5
fludarabine phosphate
4
fludarabine
4
Whole-Body Irradiation
4
Prednisone
4
CT-P10
4
Biopsy
4
zanubrutinib
3
orelabrutinib
3
Vincristine
3
Mycophenolic Acid
3
Cyclosporine
3
polatuzumab vedotin
2
pirtobrutinib
2
Tacrolimus
2
Peripheral Blood Stem Cell Transplantation
2
Doxorubicin
2
Busulfan
2
Bendamustine Hydrochloride
2
voruciclib
1
treosulfan
1
tafasitamab
1
prednylidene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, B-Cell, Marginal Zone
×
Vinorelbine
×
90 days
×
Clear all
No trials found.